{"id":"W3034425032","doi":"10.1126/science.abc5902","title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","year":2020,"lang":"en","type":"article","venue":"Science","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1349,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Universiteit van Amsterdam; Bill and Melinda Gates Foundation","keywords":"Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Antibody; Vulnerability (computing); Neutralizing antibody; Betacoronavirus; Coronavirus Infections; Chemistry; Computational biology; Biology; Immunology; Medicine; Computer science; Computer security; Outbreak; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08415653515182411,"score_gpt":0.370397834797049,"score_spread":0.2862412996452249,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}